Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV desmopressin, tranexamic acid, and combination therapy for bleeding reduction during functional endoscopic sinus surgery
IRCT20231112060028N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of desmopressin and tranexamic acid in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Duration of surgery, Total suctioned blood volume and 2 more. Started Nov 2023; status: completed.
02
Drugs
desmopressintranexamic acid
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20231112060028N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231112060028N1.